PL2173321T3 - Tabletkowane formulacje lipofilowych składników zdrowotnych - Google Patents

Tabletkowane formulacje lipofilowych składników zdrowotnych

Info

Publication number
PL2173321T3
PL2173321T3 PL08784912.1T PL08784912T PL2173321T3 PL 2173321 T3 PL2173321 T3 PL 2173321T3 PL 08784912 T PL08784912 T PL 08784912T PL 2173321 T3 PL2173321 T3 PL 2173321T3
Authority
PL
Poland
Prior art keywords
tablettable
formulations
health ingredients
lipophilic health
lipophilic
Prior art date
Application number
PL08784912.1T
Other languages
English (en)
Inventor
Sylvain Diguet
Bruno Leuenberger
Bernd Schlegel
Johann Ulm
Original Assignee
Dsm Ip Assets B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets B.V. filed Critical Dsm Ip Assets B.V.
Publication of PL2173321T3 publication Critical patent/PL2173321T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL08784912.1T 2007-07-19 2008-07-21 Tabletkowane formulacje lipofilowych składników zdrowotnych PL2173321T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92994507P 2007-07-19 2007-07-19
PCT/EP2008/005945 WO2009010305A2 (en) 2007-07-19 2008-07-21 Tablettable formulations of lipophilic health ingredients

Publications (1)

Publication Number Publication Date
PL2173321T3 true PL2173321T3 (pl) 2025-04-28

Family

ID=40198611

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08784912.1T PL2173321T3 (pl) 2007-07-19 2008-07-21 Tabletkowane formulacje lipofilowych składników zdrowotnych

Country Status (8)

Country Link
US (1) US8597642B2 (pl)
EP (1) EP2173321B1 (pl)
JP (1) JP2010533667A (pl)
KR (1) KR20100047869A (pl)
CN (1) CN101873848B (pl)
ES (1) ES3014060T3 (pl)
PL (1) PL2173321T3 (pl)
WO (1) WO2009010305A2 (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9375387B2 (en) * 2008-10-07 2016-06-28 Basf Se Ready-to-use, stable emulsion
US8747562B2 (en) 2009-10-09 2014-06-10 Philip Morris Usa Inc. Tobacco-free pouched product containing flavor beads providing immediate and long lasting flavor release
WO2013127807A1 (en) * 2012-02-28 2013-09-06 Dsm Ip Assets B.V. Extrusion process
TW201402153A (zh) * 2012-04-04 2014-01-16 Lonza Ag 菸鹼醯胺粉末和其製備方法及裝置
WO2014083065A1 (en) * 2012-11-27 2014-06-05 Dsm Ip Assets B.V. Process for the production of discrete solid extruded particles
US20160073667A1 (en) * 2013-05-06 2016-03-17 Dsm Ip Assets B.V. Powderous vitamin e formulation
US9693574B2 (en) 2013-08-08 2017-07-04 Virun, Inc. Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch
WO2015173603A1 (en) 2014-05-16 2015-11-19 Omniactive Health Technologies Limited Hydrophilic matrix beadlet compositions with enhanced bioavailability
CN104186977A (zh) * 2014-08-11 2014-12-10 嘉兴天和诚生物科技有限公司 维生素d3微粒及其生产方法
US9861611B2 (en) 2014-09-18 2018-01-09 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
US10016363B2 (en) 2014-09-18 2018-07-10 Virun, Inc. Pre-spray emulsions and powders containing non-polar compounds
CN104473168A (zh) * 2014-12-26 2015-04-01 江南大学 一种提高脂溶性活性组分溶解度与生物利用度的加工方法
WO2017063102A1 (zh) * 2015-10-12 2017-04-20 浙江医药股份有限公司新昌制药厂 一种脂溶性营养素微胶囊微粒的造粒成型干燥方法
JP6930537B2 (ja) * 2015-12-10 2021-09-01 ディーエスエム アイピー アセッツ ビー．ブイ．Ｄｓｍ Ｉｐ Ａｓｓｅｔｓ Ｂ．Ｖ． ビタミン製剤
AU2017242919B2 (en) * 2016-04-01 2020-03-26 Dsm Ip Assets B.V. New tablettable formulation of lutein and/or zeaxanthin
CN107594597B (zh) 2017-07-31 2020-05-12 浙江新和成股份有限公司 一种脂溶性营养素微胶囊及其制备方法
JP7166754B2 (ja) 2017-11-22 2022-11-08 沢井製薬株式会社 ダサチニブ無水物含有製剤
WO2019101832A1 (en) 2017-11-27 2019-05-31 Dsm Ip Assets B.V. Freeze-dried multiparticulate solid dosage form
WO2019175331A1 (en) * 2018-03-15 2019-09-19 Dsm Ip Assets B.V. Extrusion of oxidable actives
EP3764993A1 (en) * 2018-03-15 2021-01-20 DSM IP Assets B.V. Extrudate comprising vitamin a
TW201943410A (zh) 2018-04-10 2019-11-16 荷蘭商帝斯曼知識產權資產管理有限公司 具有彈性結構之多顆粒固體劑型
JP7315287B2 (ja) * 2018-04-27 2023-07-26 ディーエスエム アイピー アセッツ ビー．ブイ． 粉末状製剤
CN117202889A (zh) * 2021-04-16 2023-12-08 帝斯曼知识产权资产管理有限公司 视黄醇制剂（ii）

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59137410A (ja) * 1983-01-27 1984-08-07 Riken Vitamin Co Ltd 安定な粉末ビタミンａの製造法
JPS59161314A (ja) * 1983-03-06 1984-09-12 Taiho Yakuhin Kogyo Kk 安定化ユビキノン組成物の製法
JPH06172170A (ja) * 1992-02-13 1994-06-21 T Hasegawa Co Ltd カロチノイド含有粉末製剤
ATE221772T1 (de) * 1994-06-14 2002-08-15 Biovail Tech Ltd Verfahren und apparat zur herstellung von schnelllöslichen dosierungseinheiten und daraus erhältliches produkt
WO1999017746A1 (fr) * 1997-10-07 1999-04-15 Eisai Co., Ltd. Procede de preparation de poudre emulsionnee
JP4028642B2 (ja) * 1997-10-07 2007-12-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 乳化粉末の製造方法
ATE270676T1 (de) * 1997-10-31 2004-07-15 Nat Starch Chem Invest Mit glukoamylase umgesetzte stärkederivate und ihre verwendung als emulgatoren und einkapselungsmittel
US5935826A (en) * 1997-10-31 1999-08-10 National Starch And Chemical Investment Holding Corporation Glucoamylase converted starch derivatives and their use as emulsifying and encapsulating agents
US6077558A (en) * 1998-12-23 2000-06-20 Bristol-Myers Squibb Company Elemental nutritional products
DE60014255T2 (de) * 1999-07-06 2005-11-03 Dsm Ip Assets B.V. Zusammensetzung, die fettlösliche Substanzen in einer Kohlenhydratmatrix enthält
DE10003493A1 (de) * 2000-01-27 2001-08-09 Wacker Chemie Gmbh Verfahren zur Herstellung eines Koezym Q10-/y-Cyclodextrin Komplexes
DE10158046A1 (de) * 2001-11-27 2003-06-05 Basf Ag Formulierung für den Einsatz in Lebensmitteln, Nahrungsergänzungsmitteln, Futtermitteln, Futterzusatzstoffen, pharmazeutischen und kosmetischen Zubereitungen sowie Verfahren zu deren Herstellung
CN1633245A (zh) * 2002-02-14 2005-06-29 Dsmip资产有限公司 水可分散的辅酶q10干粉
AU2003257313A1 (en) * 2002-08-13 2004-02-25 Vitalstate Canada Ltd. Multi-phase delivery system comprising a semi-solid matrix phase
JP4138511B2 (ja) * 2003-01-24 2008-08-27 太陽化学株式会社 色素の退色防止剤
EP1761515B1 (de) * 2003-12-20 2008-11-05 MERCK PATENT GmbH 2-(hetero-)aryl substituierte tetrahydrochinolinderivate
US8658206B2 (en) * 2004-06-25 2014-02-25 Mokwalo SA Compositions comprising strontium and vitamin D and uses thereof
DE102004046026A1 (de) * 2004-09-21 2006-03-23 Basf Ag Verfahren zur Herstellung von Trockenpulvern eines oder mehrerer Carotinoide
CN101115404B (zh) * 2005-02-02 2013-06-05 帝斯曼知识产权资产管理有限公司 粉末组合物
ES2324957T5 (es) * 2005-03-04 2012-08-21 Nycomed Pharma As Proceso para la producción de composiciones de calcio en un lecho fluido continuo
DE102005030952A1 (de) * 2005-06-30 2007-01-18 Basf Ag Verfahren zur Herstellung einer wässrigen Suspension und einer pulverförmigen Zubereitung eines oder mehrerer Carotinoide
EP1903887A1 (en) * 2005-07-20 2008-04-02 DSMIP Assets B.V. Novel stabilized carotenoid compositions
WO2007014566A2 (en) * 2005-08-04 2007-02-08 Basf Aktiengesellschaft Microcapsules and their use
JP2007063249A (ja) * 2005-09-01 2007-03-15 Shinko Boeki Kk コエンザイムｑ１０包接体
WO2007045488A1 (en) * 2005-10-21 2007-04-26 Dsm Ip Assets B.V. Novel formulations of fat-soluble active ingredients with high bioavailability
CN100457150C (zh) * 2005-11-25 2009-02-04 浙江省医学科学院 缓解视疲劳的胶囊或片剂及其制备方法
EP1981915B1 (en) * 2006-02-06 2018-04-25 DSM IP Assets B.V. Compositions of active ingredients
EP1935410A1 (en) * 2006-12-22 2008-06-25 Basf Se Microcapsules

Also Published As

Publication number Publication date
WO2009010305A3 (en) 2009-03-05
CN101873848A (zh) 2010-10-27
US20100284987A1 (en) 2010-11-11
US8597642B2 (en) 2013-12-03
WO2009010305A2 (en) 2009-01-22
ES3014060T3 (en) 2025-04-16
CN101873848B (zh) 2014-12-10
JP2010533667A (ja) 2010-10-28
EP2173321A2 (en) 2010-04-14
KR20100047869A (ko) 2010-05-10
EP2173321B1 (en) 2024-12-18

Similar Documents

Publication Publication Date Title
PL2173321T3 (pl) Tabletkowane formulacje lipofilowych składników zdrowotnych
ZA200900345B (en) Preparation of pharmaceutical formulations
IL200198A0 (en) Formulations of lipophilic bioactive molecules
PL2200588T3 (pl) Kompozycje zawierające lipofilowe związki aktywne i sposób ich wytwarzania
GB0915693D0 (en) Fatty acid formulations and methods of use thereof
IL187957A0 (en) Liquid pharmaceutical formulations of docetaxel
SG10201401995UA (en) Stable high protein concentration formulations of human anti-tnf-alpha-antibodies
IL220465A0 (en) Methods and compositions for stable liquid drug formulations
PL2066179T3 (pl) Formulacje zawierające indoksakarb do miejscowego podawania na skórę
SI2194969T1 (sl) Lipidne formulacije, ki vsebujejo kislino
EP2004175A4 (en) COMPOUNDS AND FORMULATIONS FOR INCREASING THE EFFECT OF CANCER AND METHOD FOR THEIR USE
IL218113A0 (en) Stable liquid oily ready-to-use formulations, preparation thereof and use thereof
ZA201007107B (en) Film-shaped preparation comprising oily substances for oral administration
GB0718435D0 (en) Wpund care formulation
PT2173345E (pt) Formulação oral de metadoxina
IL217841A0 (en) Long lasting drug formulations
IL194366A0 (en) Solid dosage formulations
EP2185112A4 (en) Stabilized therapeutic compositions and formulations
ZA200807486B (en) Medicament formulations comprising fluoroquinolones
IL206577A0 (en) Formulations of flibanserin
IL213711A (en) Nano-phenofibrate preparation
IL198160A0 (en) Pharmaceutical formulations
ZA201101214B (en) Formulations of canfosfamide and their preparation
IL209833A0 (en) Solid dosage formulations of telcagepant potassium
GB0615586D0 (en) Cream formulations